BRIEF-FDA To Discontinue Pfizer's Mensest tablet

Reuters
29 Jul
BRIEF-FDA To Discontinue Pfizer's Mensest tablet

July 29 (Reuters) - FDA:

  • FDA: DISCONTINUATION OF MANUFACTURE OF PFIZER'S MENEST, TABLET, .3 MG & MENEST, TABLET, .625 MG- WEBSITE

  • FDA: DISCONTINUATION OF MANUFACTURE OF PFIZER'S MENEST TABLET, 1.25 MG & MENEST TABLET, 2.5 MG - WEBSITE

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10